Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Open-market sale Chief Medical Officer sold 56,726 shares at an average $26.94 ($1,528,324)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Medical Officer sold 34,600 shares at an average $22.08 ($764,002)
  10. 4 Open-market sale Chief Medical Officer sold 19,175 shares at an average $19.18 ($367,745)
  11. 4 Open-market sale Vice President, Finance sold 1,844 shares at $17.77 ($32,768)
  12. 4 Open-market sale Chief Medical Officer sold 14,975 shares at $18.14 ($271,681)
  13. 4 Open-market sale Chief Medical Officer sold 4,200 shares at $18.04 ($75,786)
  14. 4 Grant or award Vice President, Finance acquired 16,000 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
  16. 4 Grant or award Chief Development Officer acquired 45,000 shares (grant or award)
  17. 4 Grant or award President and COO acquired 100,000 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
  19. 4 Open-market sale Chief Medical Officer sold 22,300 shares at an average $19.20 ($428,050)
  20. 4 Open-market sale Chief Medical Officer sold 43,800 shares at an average $22.74 ($995,874)

Page 10 of 16 · 301 filings